{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=91740&answeringDeptId=201", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=91740&answeringDeptId=201", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=91740&answeringDeptId=201&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=91740&_page=0&answeringDeptId=201", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=91740&answeringDeptId=201", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=91740&answeringDeptId=201", "items" : [{"_about" : "http://data.parliament.uk/resources/1236495", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1236495/answer", "answerText" : {"_value" : "

The Government is leading efforts to find and manufacture a vaccine, working with industry and experts, both here in the UK and internationally to ensure we are in the best position possible to support the discovery, manufacture and mass-deployment of a successful vaccine should a candidate prove successful. A number of agreements to procure millions of doses of vaccines have been made, ensuring the greatest possible chance of securing access to a safe and effective vaccine. The UK has now secured access to 6 different candidates, across 4 different vaccines types, including University of Oxford\u2019s vaccine being developed with AstraZeneca and agreements with BioNTech/Pfizer alliance, Valneva, Novavax, Janssen and GSK/Sanofi Pasteur.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4372", "label" : {"_value" : "Biography information for Amanda Solloway"} } , "answeringMemberConstituency" : {"_value" : "Derby North"} , "answeringMemberPrinted" : {"_value" : "Amanda Solloway"} , "dateOfAnswer" : {"_value" : "2020-09-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-09-22T15:14:07.357Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2020-09-17", "_datatype" : "dateTime"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what progress is being made on the development of a covid-19 vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4860", "label" : {"_value" : "Biography information for Dr Kieran Mullan"} } , "tablingMemberConstituency" : {"_value" : "Crewe and Nantwich"} , "tablingMemberPrinted" : [{"_value" : "Dr Kieran Mullan"} ], "uin" : "91740"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }